Edwards Lifesciences Says TAVR Cuts Death or Heart Failure Events by Over 30%
Edwards Lifesciences reported that TAVR delivers an over 30% reduction in death or heart failure events versus clinical surveillance.
Story updates
05:40:45 PM UTC
SquawkNews
Edwards Lifesciences, TAVR riduce del 33% rischio di morte o eventi di scompenso cardiaco in pazient